cervical cancer
AstraZeneca’s Imfinzi fails in cervical cancer bid
Phil Taylor
AstraZeneca, cervical cancer, Imfinzi, immuno-oncology, Keytruda, Merck & Co, Oncology
0 Comment
FDA clears Seagen, Genmab’s Tivdak ADC for cervical cancer
Phil Taylor
cervical cancer, fda, Genmab, Oncology, regulatory approval, Seagen, Tivdak
0 Comment
In a class first, Merck’s Keytruda extends survival in cervical cancer
Phil Taylor
cervical cancer, immuno-oncology, Keytruda, Merck & Co, Oncology
0 Comment
Sanofi, Regeneron prep filings for Libtayo in cervical cancer
Phil Taylor
cervical cancer, immuno-oncology, Libtayo, Oncology, Regeneron, Sanofi
0 Comment
Seagen and Genmab file ‘trojan horse’ drug with FDA for cervical cancer
Richard Staines
cancer, cervical cancer, fda, Genmab, R&D, Seagen
0 Comment
AI device could be cheaper and more accurate than smear tests
Richard Staines
AI, artificial intelligence, cervical cancer, Lancor Scientific
0 Comment
News/ News/ Oncology/ Top stories
FDA approves Keytruda in cervical cancer
Richard Staines
cervical cancer, Keytruda, Merck & Co
0 Comment